Contact this trialFirst, we need to learn more about you.
Antiviral Agent
Nirmatrelvir + Ritonavir for Long COVID
Recruiting0 awardsPhase 2
New Haven, Connecticut
This trial will test an anti-viral agent to improve general health status in people with long COVID, and will also collect immune signatures associated with treatment response. It is designed to make it convenient to participate.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.